Sökning: "F A Karlsson"
Visar resultat 1 - 5 av 27 avhandlingar innehållade orden F A Karlsson.
1. Evaluating credal set theory as a belief framework in high-level information fusion for automated decision-making
Sammanfattning : High-level information fusion is a research field in which methods for achieving an overall understanding of the current situation in an environment of interest are studied. The ultimate goal of these methods is to provide effective decision-support for human or automated decision-making. LÄS MER
2. Genomic characterization of non-small cell lung cancer - clinical and molecular implications
Sammanfattning : Lung cancer accounts for 1.6 million cancers annually and 1.3 million deaths per year make the disease the deadliest type of cancer. Smoking is the most prominent cause. LÄS MER
3. Infrared spectroscopy as a tool to reconstruct past lake-ecosystem changes : Method development and application in lake-sediment studies
Sammanfattning : Natural archives such as lake sediments allow us to assess contemporary ecosystem responses to climate and environmental changes in a long-term context beyond the few decades to at most few centuries covered by monitoring or historical data. To achieve a comprehensive view of the changes preserved in sediment records, multi-proxy studies – ideally in high resolution – are necessary. LÄS MER
4. Arbetarrörelsen, Folkets Hus och offentligheten i Bromölla 1905-1960
Sammanfattning : The purpose of this dissertation is to analyze the People’s House in Bromölla as an arena for a plebeian public sphere. More specific, the analysis revolves around how the labour movement created a plebeian public sphere, the construction of the very arena and the activities there, including study circles, labour library, theatre plays, film showings, dance evenings and other amusements as parts of adult education among the working class people. LÄS MER
5. Mechanism-Based Pharmacokinetic and Pharmacodynamic Modelling of Paclitaxel
Sammanfattning : Paclitaxel (Taxol®) is now widely used against breast, ovarian and non-small-cell lung cancer. Anticancer agents generally have narrow therapeutic indices, often with myelosuppression (mainly neutropenia) as dose-limiting side effect. LÄS MER